The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A multicenter audit of the incidence of febrile neutropenia and neutropenia associated with docetaxel and cyclophosphamide (TC) chemotherapy for early breast cancer.
Roopa Lakhanpal
No relevant relationships to disclose
Robin Stuart-Harris
No relevant relationships to disclose
Arlene Chan
No relevant relationships to disclose
Dusan Kotasek
No relevant relationships to disclose
Jane McNeil Beith
No relevant relationships to disclose
Katharine Cuff
No relevant relationships to disclose
Patricia A. Bastick
No relevant relationships to disclose
Clara Inkyung Lee
No relevant relationships to disclose